Figure 5. Hazard ratios (HRs) for death and 95% confidence intervals (CIs).

In subgroup analyses, (A) six cycles of treatment were associated with an improved survival in most subgroups compared with four cycles, and (B) overall survival showed no significant difference between six and eight cycles.